| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Apr 2020 - 30 Sept 2020 | 09 Feb 2021 | 56 | 14% | 48% | 38% | 54% |
| 01 Apr 2019 - 30 Sept 2019 | 01 Nov 2019 | 58 | 12% | 47% | 41% | 63% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
The company's standard payment terms are 60 days from date of invoice
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
If the supplier does not accept our standard payment terms our policy is to pay undisputed invoices within 7 days following the invoice due date
Maximum contractual payment period agreed
120
If the supplier does not agree to our standard payments terms our policy is to pay undisputed invoices within 7 days following the invoice due date.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
STERLING PHARMA SOLUTIONS LIMITED is a leading contract development and manufacturing organization (CDMO) based in the United Kingdom. The company specializes in providing innovative solutions in the pharmaceutical industry.
The company offers a range of services including process development, manufacturing, and analytical services for both small and large molecules. They also offer specialized services such as radiolabelling, stability studies, and regulatory support. With state-of-the-art facilities and a team of highly skilled experts, STERLING PHARMA SOLUTIONS LIMITED is committed to delivering high-quality products and services to their clients.
In addition to their focus on providing top-notch services, the company also has a strong sustainability program. They are dedicated to reducing their environmental impact by implementing energy-efficient processes and reducing waste generation. They also prioritize ethical and responsible sourcing of materials and have a robust health and safety program to ensure the well-being of their employees.
Key people at STERLING PHARMA SOLUTIONS LIMITED include the CEO, Kevin Cook, and the Chief Scientific Officer, Dr. Andrew Henderson. Their website address is www.sterlingpharmasolutions.com, where interested parties can find more information about their services and contact details.
The registered office address for STERLING PHARMA SOLUTIONS LIMITED is 1-2-3 Innovation Way, Northumberland, NE61 0BQ, United Kingdom. Overall, STERLING PHARMA SOLUTIONS LIMITED is a highly reputable and sustainable company that is committed to providing top-quality products and services in the pharmaceutical industry.
Proud of your payment record? Show your live score on your own site:
<iframe src="https://paymentcheck.co.uk/badge/05712796" width="240" height="72" style="border:0" title="PaymentCheck Score" loading="lazy"></iframe>